Transplantation of HIF-1α-overexpressing MSCs in mice with experimental colitis resulted in good immune balance and mucosal rehabilitation, thereby proving a potentially effective treatment for IBD or other inflammatory diseases that can be applied in the future. Here, HIF1A is linked to inflammatory bowel disease.